Summit's Lung Cancer Drug: A Tale of Two Continents
Summit Therapeutics' promising lung cancer drug, ivonescimab, shows great results in China but struggles in Western trials, raising questions about its global future and impact on biotech.
/ 1 item
#SMMT↓